Sector Gamma AS cut its holdings in Elanco Animal Health (NASDAQ:ELAN) by 15.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 185,042 shares of the company’s stock after selling 33,952 shares during the period. Elanco Animal Health comprises about 1.0% of Sector Gamma AS’s holdings, making the stock its 28th largest position. Sector Gamma AS owned 0.05% of Elanco Animal Health worth $6,254,000 at the end of the most recent quarter.
Other institutional investors have also bought and sold shares of the company. Saturna Capital CORP grew its holdings in shares of Elanco Animal Health by 25.7% during the second quarter. Saturna Capital CORP now owns 16,129 shares of the company’s stock worth $545,000 after buying an additional 3,300 shares during the last quarter. Aperio Group LLC purchased a new position in shares of Elanco Animal Health during the second quarter worth about $90,000. KBC Group NV grew its holdings in shares of Elanco Animal Health by 11.9% during the second quarter. KBC Group NV now owns 265,845 shares of the company’s stock worth $8,986,000 after buying an additional 28,320 shares during the last quarter. BNP Paribas Arbitrage SA grew its holdings in shares of Elanco Animal Health by 4.8% during the second quarter. BNP Paribas Arbitrage SA now owns 69,714 shares of the company’s stock worth $2,356,000 after buying an additional 3,210 shares during the last quarter. Finally, Aviva PLC grew its holdings in shares of Elanco Animal Health by 5.9% during the second quarter. Aviva PLC now owns 130,172 shares of the company’s stock worth $4,400,000 after buying an additional 7,309 shares during the last quarter.
Shares of ELAN stock traded up $0.24 during midday trading on Tuesday, reaching $29.92. 123,681 shares of the company traded hands, compared to its average volume of 5,804,434. The business’s 50 day moving average price is $33.17. Elanco Animal Health has a 1-year low of $28.00 and a 1-year high of $37.61.
A number of equities research analysts have weighed in on ELAN shares. BMO Capital Markets lifted their price objective on Elanco Animal Health from $32.00 to $35.00 and gave the company a “market perform” rating in a report on Friday, May 10th. Zacks Investment Research lowered Elanco Animal Health from a “buy” rating to a “hold” rating in a report on Wednesday, July 10th. Finally, Guggenheim started coverage on Elanco Animal Health in a report on Wednesday, May 22nd. They issued a “neutral” rating on the stock. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $33.56.
About Elanco Animal Health
There is no company description available for Elanco Animal Health Inc
Further Reading: 52-Week High/Low
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.